EUVIMEDObjevte EUVIMED
LeserbriefOpen access

Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety

Yousef Hakimi iD, Edward Giles

Alimentary Pharmacology & Therapeutics · 2026-10 · 64 (7) · 1021-1022

DOI: 10.1111/apt.70830 ↗

At a glance

Leserbrief in Alimentary Pharmacology & Therapeutics, published online on 2026-06-29. Written by Yousef Hakimi and 1 co-authors. Institution: Monash Health, Clayton, Victoria, Australia. Cited 1 times so far (Crossref); 9 references. The full text is freely available in PubMed Central.

AbstraktBibliografické údajeCiteRelated studies

Abstract (original language)

Není k dispozici žádný abstrakt.

Authors and institutions

  • Monash Health, Clayton, Victoria, Australia.
  • Department of Paediatrics, Monash University, Clayton, Victoria, Australia.
  • Centre for Innate Immunity and Infectious Disease, Hudson Institute of Medical Research, Clayton, Victoria, Australia.

ORCID profiles: Yousef Hakimi

Cite

APA

Hakimi, Y., & Giles, E. (2026). Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety. Alimentary Pharmacology & Therapeutics, 64(7), 1021-1022. https://doi.org/10.1111/apt.70830

Vancouver

Hakimi Y, Giles E. Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety. Alimentary Pharmacology & Therapeutics. 2026;64(7):1021-1022. doi:10.1111/apt.70830

BibTeX
@article{Hakimi2026,
  author = {Hakimi, Yousef and Giles, Edward},
  title = {Letter: Low FODMAP Therapy in Paediatric Irritable Bowel Syndrome: Balancing Efficacy, Expectancy and Safety},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {64},
  number = {7},
  pages = {1021--1022},
  doi = {10.1111/apt.70830}
}
Start for free →